An aromatic diamidine that targets the kDNA, impairs the cell cycle in Trypanosoma...
| Full text | |
| Author(s): |
Girard, Richard M. B. M.
;
Crispim, Marcell
;
Stolic, Ivana
;
Damasceno, Flavia Silva
;
da Silva, Marcelo Santos
;
Furusho Pral, Eizabeth Mieko
;
Elias, Maria Carolina
;
Bajic, Miroslav
;
Silber, Ariel Mariano
Total Authors: 9
|
| Document type: | Journal article |
| Source: | Antimicrobial Agents and Chemotherapy; v. 60, n. 10, p. 5867-5877, OCT 2016. |
| Web of Science Citations: | 5 |
| Abstract | |
Trypanosoma cruzi is the etiological agent of Chagas disease, affecting approximately 10 million people in the Americas and with some 40 million people at risk. The objective of this study was to evaluate the anti-T. cruzi activity of three new diamidines that have a 3,4-ethylenedioxy extension of the thiophene core, designated MB17, MB19, and MB38. All three diamidines exhibited dose-dependent inhibition of epimastigote replication. The mechanisms of action of these diamidines were investigated. Unlike MB17 and MB19, MB38 exhibited a significant increase in the number of annexin-propidium iodide double-labeled cells compared to levels in control parasites. As MB17 had shown a lower 50% inhibitory concentration (IC50) against epimastigote growth, the mechanism of action of this drug was studied in more detail. MB17 triggered a decrease in the intracellular ATP levels. As a consequence, MB17 affected the genomic DNA and kinetoplast DNA (kDNA) and impaired the parasite cell cycle. Moreover, MB17 caused DNA fragmentation, with a more severe effect on kDNA than on nuclear DNA, resulting in dyskinetoplastic cells. MB17 was tested for toxicity and effectiveness for the treatment of infected CHO-K-1 cells, exhibiting a 50% cytotoxic concentration (CC50) of 13.47 +/- 0.37 mu Mand an IC50 of 0.14 +/- 0.12 mu Magainst trypomastigote release. MB17 also diminished the infection index by 60% at 0.5 mu M. In conclusion, despite belonging to the same family, these diamidines have different efficiencies. To summarize, MB17 was the most potent of these diamidines against epimastigotes, producing DNA damage preferentially in kDNA, impairing the parasite cell cycle, and decreasing the infection index and trypomastigote release from infected mammalian host cells, with a high selectivity index (SI) (< 90). These data suggest that MB17 could be an interesting lead compound against T. cruzi. (AU) | |
| FAPESP's process: | 13/07467-1 - CeTICS - Center of Toxins, Immune-Response and Cell Signaling |
| Grantee: | Hugo Aguirre Armelin |
| Support type: | Research Grants - Research, Innovation and Dissemination Centers - RIDC |
| FAPESP's process: | 13/18970-6 - Characterization of the Disulfiram effect in Trypanosoma cruzi |
| Grantee: | Ariel Mariano Silber |
| Support type: | Regular Research Grants |